Use of dermal equivalent and skin equivalent models for in vitro cutaneous irritation testing of cosmetic products: Comparison with in vivo human data

Journal of Toxicology - Cutaneous and Ocular Toxicology

Volumn 17, Issue 1, 1998, Pages 5-17

  Augustin, Corinne ^a   Collombel, Christian ^a   Damour, Odile ^a,b  

^a Pavillon 15 Hôpital Edouard Herriot   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC;

ARTICLE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRY SKIN; EDEMA; ERYTHEMA; HUMAN; PATCH TEST; SCORING SYSTEM; SKIN IRRITATION; SKIN TEST;

ANIMALIA;

EID: 0031945584     PISSN: 07313829     EISSN: None     Source Type: Journal    
DOI: 10.3109/15569529809049300     Document Type: Article

References (46)

1. J. Draize, G. Woodard, and H. Calvery, Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membrane, J. Pharmacol. Exp. Ther. 82: 377-390, 1944.
2. N. Loprieno and G. Loprieno, Cosmetic regulation in the European union, In Vitro Toxicol. 8: 419-426, 1995.
3. N. Loprieno, L. Bruner, G. Carr, M. Chamberlain, M. Cottin, O. De Silva, and S. Kato, Alternatives in cosmetics testing, In Vitro Toxicol. 9: 827-838, 1995.
4. W. Broeckx, A. Blondeel, A. Booms-Gossens, and G. Achten, Cosmetic intolerance, Contact Derm. 16:189-194, 1987.
5. A. De Groot, D. Bruynzeel, J. Bos, H. Van Der Meeren, T. Van Joost, B. Jagtman, and J. Weyland, The allergens in cosmetics, Arch. Dermatol. 124: 1525-1529, 1988.
6. A. Pons-Guiraud, Tolérance aux cosmétiques: le point en 1995, Nouv. Dermatol. 14: 514-521, 1995.
7. J. Auffranc, P. Berbis, and Y. Privat, Les tests prédictifs cutanés, J. Méd. Esth. Chir. Derm. 13: 39-42, 1986.
8. A. Pons-Guiraud, Intolérance aux cosmétiques, Nouv. Dermatol. 10: 43-47, 1991.
9. A. Walker, D. Basketter, M. Bareve, W. Diembeck, W. Matthies, D. Mougin, M. Paye, R. Rothlisberger, and J. Dupuis, Test guidelines for assessment of skin compatibility of cosmetic finished products in man, Food Chem. Toxicol. 34: 651-660, 1996.
10. H. Shelanski and M. Shelanski, A new technique of human patch tests, The Toilet Goods Association, Proceedings of Scientific Section, 19, 46-49, 1953.
11. T. Fischer and I. Kihlman, Patch testing technique, J. Am. Acad. Dermatol. 21: 830-832, 1989.
12. F. Bartnik, W. Pitterman, N. Mendorf, U. Tillman, and K. Kunstler, Skin organ culture for the study of skin irritancy, Toxicol. in Vitro 4: 293-301, 1990.
13. J. Kao, J. Hall, and J. Holland, Quantitation of cutaneous toxicity: An in vitro approach using skin organ culture, Toxicol. Appl. Pharmacol. 68: 206-217, 1983.
14. A. Gueniche and M. Ponec, Use of human skin cell cultures for the estimation of potential skin irritants, J. Toxicol. Cut. Ocular Toxicol. 12: 49-57, 1993.
15. R. Osborne and M. Perkins, In vitro skin irritation testing with human skin cell cultures, Toxicol. in Vitro 5: 563-567, 1991.
16. D. Swisher, M. Cormier, J. Johnson, and P. Ledger, A cytotoxicity assay using normal keratinocytes: Characterization and application, Models Dermatol. 4: 131-137, 1988.
17. K. Wallace, J. Harbell, A. Triana, N. Accomando, and S. Valone, Evaluation of the human epidermal keratinocyte neutral red release and neutral red uptake assay using the first 10 MIEC materials, Toxicol. in Vitro 6: 367-371, 1992.
18. M. Rosdy and L. Clauss, Terminal epidermal differentiation of human keratinocytes grown chemically defined medium on inert filter substrates at the air-liquid interface, J. Invest. Dermatol. 96: 409-414, 1990.
19. E. Bell, B. Ivarson, and C. Merrill, Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro, Cell Biol. 76: 1274-1278, 1979.
20. D. Laska, R. Poulsen, J. Horn, V. Meador, and D. Hoover, An evaluation of Testskin: An alternative dermal irritation model, In Vitro Toxicol. 5: 177-189, 1992.
21. C. Augustin, C. Collombel, and O. Damour, Development of a kit for predicting cutaneous toxicity in vitro using 3-D dermal equivalent: Phase 1. Reproducibility of dermal equivalent, J. Cell. Eng. 1: 58-62, 1995.
22. E. Bell, M. Rosenberg, P. Kemp, R. Gay, G. Green, N. Muthukumaran, and C. Nolte, Recipes for reconstituting skin, J. Biomed. Eng. 113: 113-119, 1991.
23. M. Regnier, D. Asselineau, and M. Lenoir, Human epidermis reconstructed on dermal substrates in vitro: An alternative to animals in skin pharmacology, Skin Pharmacol. 3: 70-85, 1990.
24. S. Boyce, D. Christianson, and J. Hansbrough, Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes, J. Biomed. Mater. 22: 939-957, 1988.
25. L. Shahabeddin, F. Berthod, O. Damour, and C. Collombel, Characterisation of skin reconstructed on a chitosan cross-linked collagen glycosaminoglycan matrix, Skin Pharmacol. 3: 107-114, 1989.
26. R. Roguet, C. Cohen, and J. Leclaire, The use of a reconstructed human epidermis Episkin for the assessment of safety and efficacy of cosmetic products, In Vitro Toxicol. 8: 427-429, 1995.
27. G. Naughton, L. Jacob, and B. Naughton, A physiological skin model for in vitro toxicity studies. In, In Vitro Toxicology: Mechanisms and New Technology, A. Goldberg, Ed., Mary A. Liebert Inc., New York, 1989, pp. 183-189.
28. G. Saintigny, M. Bonnard, O. Damour, and C. Collombel, Reconstruction of epidermis on a chitosan cross-linked collagen-GAG lattice: Effects of fibroblasts, Acta Derm. Venereol. 73: 175-180, 1993.
29. F. Sahuc, K. Nakazawa, F. Berthod, C. Collombel, and O. Damour, Mesenchymal-epidermal interactions regulate gene expression of type VII collagen and kalinin in keratinocytes and dermal-epidermal junction formation in a skin equivalent model, Wound Repair Regen. 4(1): 93-102, 1995.
30. F. Berthod, O. Damour, and C. Collombel, Collagen synthesis by fibroblasts cultured within a collagen sponge, Biomaterials 14: 749-754, 1993.
31. F. Berthod, F. Sahuc, D. Hayek, O. Damour, and C. Collombel, Deposition of collagen fibril bundles by long-term culture of fibroblasts in a collagen sponge, J. Biomed. Mater. Res. 32: 87-94, 1996.
32. C. Augustin, C. Collombel, and O. Damour, Use of in vitro dermal equivalent and skin equivalent kits for evaluating cutaneous toxicity of cosmetics products, In Vitro Toxicol. 10(1): 21-29, 1997.
33. C. Collombel, O. Damour, C. Gagnieu, C. Marichy, and F. Poinsignon, Biomaterials with a base of collagen, chitosan, and glycosaminoglycans: Process for preparing them and their application in human medicine. French patent 8708252, 1987; European patent 884101948, 1988; US patent PCT/FR/8800303, 1989.
34. H. Green, Terminal differentiation of cultured human epidermal cells, Cells 11: 405-416, 1977.
35. T. Mossman, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay, J. Immunol. Methods 65: 55-63, 1983.
36. E. Berardesca and F. Distante, The modulation of skin irritation, Contact Derm. 31: 281-287, 1994.
37. C. Willis, C. Stephens, and J. Wilkinson, Experimentally induced irritant contact dermatitis, Contact Derm. 18: 20-24, 1988.
38. K. Lammintausta, H. Maibach, and D. Wilson, Irritant reactivity in males and females, Contact Derm. 17: 276-280, 1988.
39. M. Judge, H. Griffiths, D. Basketter, I. White, R. Rycroft, and J. McFadden, Variation in response of human skin to irritant challenge, Contact Derm. 34: 115-117, 1996.
40. E. Berardesca and H. Maibach, Racial differences in skin pathophysiology, J. Am. Acad. Dermatol. 34: 667-672, 1996.
41. H. Van, R. Williams, P. Doherty, and D. Williams, A study of the reproducibility of the MTT test, J. Mater. Sci. 5: 154-159, 1994.
42. D. Laska, R. Poulsen, J. Horn, V. Meador, and D. Hoover, An evaluation of Testskin an alternative dermal irritation model, In Vitro Toxicol. 177: 189-185, 1992.
43. C. Augustin, C. Collombel, and O. Damour, Pharmacotoxicological applications of an equivalent dermis: Three measurements of cytotoxicity, Cell Biol. Toxicol. 11: 167-171, 1995.
44. T. Kupper, The activated keratinocyte: A model for inducible cytokine production by non-bone-marrow-derived cells in cutaneous inflammatory and immune response, J. Invest. Dermatol. 94: 146S-150S, 1990.
45. J. Harvell, Y. Tsai, H. Maibach, R. Gay, V. Gordon, K. Miller, and G. Mun, An in vivo correlation with three in vitro assays to assess skin irritation potential, J. Toxicol. Cut. Ocular Toxicol. 13: 171-183, 1994.
46. R. Gay, M. Swiderek, D. Nelson, and A. Ernesti, The living skin equivalent as a model in vitro for ranking the toxic potential of dermal irritants, Toxicol. In Vitro 6: 303-309, 1992.